4 results on '"Cotugno, Sergio"'
Search Results
2. Interventions for Improving Long COVID-19 Symptomatology: A Systematic Review.
- Author
-
Veronese, Nicola, Bonica, Roberta, Cotugno, Sergio, Tulone, Ottavia, Camporeale, Michele, Smith, Lee, Trott, Mike, Bruyere, Olivier, Mirarchi, Luigi, Rizzo, Giuseppina, Bavaro, Davide Fiore, Barbagallo, Mario, Dominguez, Ligia J., Marotta, Claudia, Silenzi, Andrea, Nicastri, Emanuele, Saracino, Annalisa, and Di Gennaro, Francesco
- Subjects
POST-acute COVID-19 syndrome ,SYMPTOMS ,DIETARY supplements ,CLINICAL trials ,RANDOMIZED controlled trials - Abstract
Introduction: Although the understanding of several aspects of long COVID-19 syndrome is increasing, there is limited literature regarding the treatment of these signs and symptoms. The aim of our systematic review was to understand which therapies have proved effective against the symptoms of long COVID-19. Methods: A systematic search for randomized controlled or clinical trials in several databases was conducted through 15 May 2022. Specific inclusion criteria included: (1) intervention studies, either randomized controlled (RCTs) or clinical trials; (2) diagnosis of long COVID-19, according to the World Health Organization criteria; (3) presence of long COVID-19 for at least 12 weeks after SARS-CoV-2 infection. Results: We initially found 1638 articles to screen. After removing 1602 works based on their title/abstract, we considered 35 full texts, and among them, two intervention studies were finally included. The first RCT focused on the greater improvement of treatment combining olfactory rehabilitation with oral supplementation with Palmitoylethanolamide and Luteolin in patients with olfactory dysfunction after COVID-19. The second study evaluated the positive impact of aromatherapy vs. standard care in adult females affected by fatigue. Conclusion: Our systematic review found only two intervention studies focused on patients affected by long COVID-19. More intervention studies are needed to investigate potentially positive interventions for long COVID-19 symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients.
- Author
-
Papagni, Roberta, Pellegrino, Carmen, Di Gennaro, Francesco, Patti, Giulia, Ricciardi, Aurelia, Novara, Roberta, Cotugno, Sergio, Musso, Maria, Guido, Giacomo, Ronga, Luigi, Stolfa, Stefania, Bavaro, Davide Fiore, Romanelli, Federica, Totaro, Valentina, Lattanzio, Rossana, De Iaco, Giuseppina, Palmieri, Fabrizio, Saracino, Annalisa, and Gualano, Gina
- Subjects
VITAMIN D ,TUBERCULOSIS patients ,TUBERCULOSIS ,VITAMIN A ,MYCOBACTERIUM tuberculosis ,COMMUNICABLE diseases - Abstract
Vitamin D plays a crucial role in many infectious diseases, such as tuberculosis (TB), that remains one of the world's top infectious killers with 1.5 million deaths from TB in 2021. Vitamin D suppresses the replication of Mycobacterium tuberculosis in vitro and showed a promising role in TB management as a result of its connection with oxidative balance. Our review encourages the possible in vivo benefit of a joint administration with other vitamins, such as vitamin A, which share a known antimycobacterial action with vitamin D. However, considering the low incidence of side effects even at high dosages and its low cost, it would be advisable to assess vitamin D level both in patients with active TB and high-risk groups and administer it, at least to reach sufficiency levels. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Potential Role of Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review.
- Author
-
Patti, Giulia, Pellegrino, Carmen, Ricciardi, Aurelia, Novara, Roberta, Cotugno, Sergio, Papagni, Roberta, Guido, Giacomo, Totaro, Valentina, De Iaco, Giuseppina, Romanelli, Federica, Stolfa, Stefania, Minardi, Maria Letizia, Ronga, Luigi, Fato, Ilenia, Lattanzio, Rossana, Bavaro, Davide Fiore, Gualano, Gina, Sarmati, Loredana, Saracino, Annalisa, and Palmieri, Fabrizio
- Subjects
VITAMIN A ,TUBERCULOSIS ,VITAMIN B6 ,MYCOBACTERIUM tuberculosis ,DIETARY supplements - Abstract
(1) Background: Tuberculosis (TB) is one of the world's top infectious killers, in fact every year 10 million people fall ill with TB and 1.5 million people die from TB. Vitamins have an important role in vital functions, due to their anti-oxidant, pro-oxidant, anti-inflammatory effects and to metabolic functions. The aim of this review is to discuss and summarize the evidence and still open questions regarding vitamin supplementation as a prophylactic measure in those who are at high risk of Mycobacterium tuberculosis (MTB) infection and active TB; (2) Methods: We conducted a search on PubMed, Scopus, Google Scholar, EMBASE, Cochrane Library and WHO websites starting from March 1950 to September 2021, in order to identify articles discussing the role of Vitamins A, B, C, D and E and Tuberculosis; (3) Results: Supplementation with multiple micronutrients (including zinc) rather than vitamin A alone may be more beneficial in TB. The WHO recommend Pyridoxine (vitamin B6) when high-dose isoniazid is administered. High concentrations of vitamin C sterilize drug-susceptible, MDR and extensively drug-resistant MTB cultures and prevent the emergence of drug persisters; Vitamin D suppresses the replication of mycobacterium in vitro while VE showed a promising role in TB management as a result of its connection with oxidative balance; (4) Conclusions: Our review suggests and encourages the use of vitamins in TB patients. In fact, their use may improve outcomes by helping both nutritionally and by interacting directly and/or indirectly with MTB. Several and more comprehensive trials are needed to reinforce these suggestions. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.